Rock Tech Notifies Shareholders of Upcoming Annual General & Special Meeting

Rock Tech Notifies Shareholders of Upcoming Annual General & Special Meeting

VANCOUVER, British Columbia, April 29, 2020 (GLOBE NEWSWIRE) — Rock Tech Lithium Inc. (the “Company” or “Rock Tech”) (TSX-V: RCK; Frankfurt: RJIB) announces that it will hold its Annual General & Special Meeting (the “Meeting”) on Friday, May 15, 2020 at 10:00am (Pacific Daylight Time).
All meeting materials, including the Notice of Meeting, Information Circular, Form of Proxy and Voting Instruction Form have been mailed to shareholders of record as of April 9, 2020. Owing to concerns surrounding COVID-19 and recommended physical distancing measures, the Company strongly encourages shareholders to utilize advanced voting measures, such as telephone or internet voting, rather than attend the Meeting in person. Instructions for voting via telephone and internet can be found on the Form of Proxy and Voting Instruction Form. Copies of all meeting materials are available on SEDAR.If you are a shareholder and wish to attend the Meeting, please contact Brad Barnett, Chief Financial Officer and Corporate Secretary of the Company, at bbarnett@rocktechlithium.com or +1.778.358.5200.On behalf of the Board of Directors,“Dirk Harbecke”
Dirk Harbecke
Chairman of the Board
For further information, please contact:Brad Barnett
Chief Financial Officer
Rock Tech Lithium Inc.
777 Hornby Street, Suite 600
Vancouver, B.C., V6Z 1S4
Telephone: (778) 358-5200
Facsimile: (604) 670-0033
Email: bbarnett@rocktechlithium.com
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as, “forward‐looking statements”.  Forward‐looking statements may be identified by words including “anticipates”, “believes”, “intends”, “estimates”, “expects” and similar expressions.  The Company cautions readers that forward‐looking statements, including without limitation those relating to the Company’s future operations and business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward‐looking statements. 
CBJ Newsmakers

Recommended
WPD Pharmaceutical’s Annamycin Drug Approved for Accelerated European Clinical TrialUniting Virtually to Support Canadians Affected by MS